Detalles de la búsqueda
1.
Nonsteroidal anti-inflammatory drug-sparing effect of secukinumab in patients with radiographic axial spondyloarthritis: 4-year results from the MEASURE 2, 3 and 4 phase III trials.
Rheumatol Int
; 42(2): 205-213, 2022 02.
Artículo
en Inglés
| MEDLINE | ID: mdl-34773130
2.
Use of the Auto-inflammatory Disease Activity Index to monitor disease activity in patients with colchicine-resistant Familial Mediterranean Fever, Mevalonate Kinase Deficiency, and TRAPS treated with canakinumab.
Joint Bone Spine
; 89(6): 105448, 2022 11.
Artículo
en Inglés
| MEDLINE | ID: mdl-35944600
3.
Secukinumab Demonstrates Sustained Efficacy and Safety in a Taiwanese Subpopulation With Active Ankylosing Spondylitis: Four-Year Results From a Phase 3 Study, MEASURE 1.
Front Immunol
; 11: 561748, 2020.
Artículo
en Inglés
| MEDLINE | ID: mdl-33324394
Resultados
1 -
3
de 3
1
Próxima >
>>